Kidswell Bio Corp.

70
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3386460004
JPY
211.00
-8 (-3.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
5,082.00
2,431.00
2,776.00
1,569.00
996.00
1,077.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
5,082.00
2,431.00
2,776.00
1,569.00
996.00
1,077.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
42.00
38.00
34.00
15.00
15.00
5.00
General and Administration Expenses
843.00
920.00
859.00
1,089.00
882.00
687.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5,054.00
3,766.00
3,327.00
2,544.00
1,966.00
2,239.00
Operating Profit (PBDIT) excl Other Income
27.00
-1,335.00
-550.00
-975.00
-969.00
-1,161.00
Other Income
86.00
-15.00
-39.00
440.00
-12.00
-17.00
Operating Profit (PBDIT)
114.00
-1,349.00
-588.00
-533.00
-981.00
-1,178.00
Interest
42.00
38.00
34.00
15.00
15.00
5.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
2.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
72.00
-1,420.00
-656.00
-549.00
-999.00
-7,314.00
Provision for Tax
94.00
1.00
1.00
1.00
1.00
2.00
Profit After Tax
-21.00
-1,422.00
-657.00
-550.00
-1,001.00
-7,316.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-0.52
-40.23
-20.77
-17.86
-34.79
-264.65
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 109.03% vs -12.43% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 102.09% vs -142.43% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 9.57% vs 11.33% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 98.51% vs -116.31% in Mar 2024

Compare Profit and Loss Results of Kidswell Bio Corp.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
5,082.00
54.00
5,028.00
9,311.11%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5,082.00
54.00
5,028.00
9,311.11%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
126.00
-126.00
-100.00%
Operating Expenses
42.00
9.00
33.00
366.67%
General and Administration Expenses
843.00
428.00
415.00
96.96%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,054.00
950.00
4,104.00
432.00%
Operating Profit (PBDIT) excl Other Income
27.00
-896.00
923.00
103.01%
Other Income
86.00
35.00
51.00
145.71%
Operating Profit (PBDIT)
114.00
-824.00
938.00
113.83%
Interest
42.00
9.00
33.00
366.67%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
0.00
36.00
-36.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
72.00
-869.00
941.00
108.29%
Provision for Tax
94.00
2.00
92.00
4,600.00%
Profit After Tax
-21.00
-872.00
851.00
97.59%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.5219
-108.344
107.82
99.52%
Profit And Loss - Net Sales
Net Sales 5,082.05 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 109.03% vs -12.43% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 27.88 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 102.09% vs -142.43% in Mar 2024

Profit And Loss - Interest
Interest 42.49 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 9.57% vs 11.33% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -21.14 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 98.51% vs -116.31% in Mar 2024